Background: Prediction of T cell immunogenicity is a topic of considerable interest, both in terms of basic understanding of the mechanisms of T cells responses and in terms of practical applications. HLA binding affinity is often used to predict T cell epitopes, since HLA binding affinity is a key requisite for human T cell immunogenicity. However, immunogenicity at the population it is complicated by the high level of variability of HLA molecules, potential other factors beyond HLA as well as the frequent lack of HLA typing data. To overcome those issues, we explored an alternative approach to identify the common characteristics able to distinguish immunogenic peptides from non-recognized peptides.
Methods: Sets of dominant epitopes derived from peer-reviewed published papers were used in conjunction with negative peptides from the same experiments/donors to train neural networks and generate an "immunogenicity score." We also compared the performance of the immunogenicity score with previously described method for immunogenicity prediction based on HLA class II binding at the population level.
Results: The immunogenicity score was validated on a series of independent datasets derived from the published literature, representing 57 independent studies where immunogenicity in human populations was assessed by testing overlapping peptides spanning different antigens. Overall, these testing datasets corresponded to over 2,000 peptides and tested in over 1,600 different human donors. The 7-allele method prediction and the immunogenicity score were associated with similar performance [average area under the ROC curve (AUC) values of 0.703 and 0.702, respectively] while the combined methods reached an average AUC of 0.725. This increase in average AUC value is significant compared with the immunogenicity score (p = 0.0135) and a strong trend toward significance is observed when compared to the 7-allele method (p = 0.0938). The new immunogenicity score method is now freely available using CD4 T cell immunogenicity prediction tool on the Immune Epitope Database website (http://tools.iedb.org/CD4episcore).
Conclusion: The new immunogenicity score predicts CD4 T cell immunogenicity at the population level starting from protein sequences and with no need for HLA typing. Its efficacy has been validated in the context of different antigen sources, ethnicities, and disparate techniques for epitope identification.
Keywords: HLA; TCR repertoire; bioinformatics; epitopes; immunodominance; immunogenicity; predictions.
Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.Immunol Res. 2016 Aug;64(4):908-18. doi: 10.1007/s12026-016-8795-9. Immunol Res. 2016. PMID: 27094547
Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes.J Immunol Methods. 2015 Jul;422:28-34. doi: 10.1016/j.jim.2015.03.022. Epub 2015 Apr 7. J Immunol Methods. 2015. PMID: 25862607 Free PMC article.
Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.BMC Bioinformatics. 2008 Dec 12;9 Suppl 12(Suppl 12):S22. doi: 10.1186/1471-2105-9-S12-S22. BMC Bioinformatics. 2008. PMID: 19091022 Free PMC article.
Immunodominance across HLA polymorphism: implications for cancer immunotherapy.J Immunother. 1998 Jan;21(1):1-16. J Immunother. 1998. PMID: 9456431 Review.
Evaluating the immunogenicity of protein drugs by applying in vitro MHC binding data and the immune epitope database and analysis resource.Clin Dev Immunol. 2013;2013:467852. doi: 10.1155/2013/467852. Epub 2013 Oct 8. Clin Dev Immunol. 2013. PMID: 24222776 Free PMC article. Review.
Cited by 11 articles
Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy.J Immunol Res. 2020 Apr 2;2020:8202067. doi: 10.1155/2020/8202067. eCollection 2020. J Immunol Res. 2020. PMID: 32322598 Free PMC article.
Structure-Based Immunogenicity Prediction of Uricase from Fungal (Aspergillus flavus), Bacterial (Bacillus subtillis) and Mammalian Sources Using Immunoinformatic Approach.Protein J. 2020 Apr;39(2):133-144. doi: 10.1007/s10930-020-09886-0. Protein J. 2020. PMID: 32221804
CD4+ Th immunogenicity of the Ascaris spp. secreted products.NPJ Vaccines. 2020 Mar 20;5:25. doi: 10.1038/s41541-020-0171-z. eCollection 2020. NPJ Vaccines. 2020. PMID: 32218997 Free PMC article.
Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions.Front Immunol. 2020 Feb 5;10:3151. doi: 10.3389/fimmu.2019.03151. eCollection 2019. Front Immunol. 2020. PMID: 32117208 Free PMC article. Review.
The Immune Epitope Database and Analysis Resource Program 2003-2018: reflections and outlook.Immunogenetics. 2020 Feb;72(1-2):57-76. doi: 10.1007/s00251-019-01137-6. Epub 2019 Nov 25. Immunogenetics. 2020. PMID: 31761977 Free PMC article. Review.
- U19 AI111211/AI/NIAID NIH HHS/United States
- U19 AI100275/AI/NIAID NIH HHS/United States
- HHSN272201200010C/AI/NIAID NIH HHS/United States
- HHSN272200900042C/AI/NIAID NIH HHS/United States
- UM1 AI114271/AI/NIAID NIH HHS/United States